nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—PTGS2—colon cancer	0.827	1	CbGaD
Salicylate-sodium—Acetylsalicylic acid—TP53—colon cancer	0.00289	0.334	CrCbGaD
Salicylate-sodium—PTGS1—endothelium—colon cancer	0.0021	0.0984	CbGeAlD
Salicylate-sodium—PTGS2—endothelium—colon cancer	0.00201	0.094	CbGeAlD
Salicylate-sodium—PTGS1—blood vessel—colon cancer	0.00194	0.0907	CbGeAlD
Salicylate-sodium—PTGS2—blood vessel—colon cancer	0.00185	0.0867	CbGeAlD
Salicylate-sodium—PTGS2—gall bladder—colon cancer	0.00174	0.0816	CbGeAlD
Salicylate-sodium—Mesalazine—PPARG—colon cancer	0.00156	0.18	CrCbGaD
Salicylate-sodium—PTGS2—embryo—colon cancer	0.00111	0.0517	CbGeAlD
Salicylate-sodium—Oesophagitis—Fluorouracil—colon cancer	0.00106	0.00744	CcSEcCtD
Salicylate-sodium—Sepsis—Irinotecan—colon cancer	0.00105	0.00738	CcSEcCtD
Salicylate-sodium—Coagulopathy—Capecitabine—colon cancer	0.00104	0.00731	CcSEcCtD
Salicylate-sodium—Deafness—Vincristine—colon cancer	0.00101	0.00708	CcSEcCtD
Salicylate-sodium—Tingling sensation—Capecitabine—colon cancer	0.00101	0.00708	CcSEcCtD
Salicylate-sodium—Sepsis—Fluorouracil—colon cancer	0.00101	0.00707	CcSEcCtD
Salicylate-sodium—Swelling—Fluorouracil—colon cancer	0.000957	0.0067	CcSEcCtD
Salicylate-sodium—Renal failure acute—Irinotecan—colon cancer	0.000954	0.00668	CcSEcCtD
Salicylate-sodium—PTGS1—epithelium—colon cancer	0.000943	0.0442	CbGeAlD
Salicylate-sodium—Disorientation—Fluorouracil—colon cancer	0.000943	0.00661	CcSEcCtD
Salicylate-sodium—Renal impairment—Irinotecan—colon cancer	0.000926	0.00648	CcSEcCtD
Salicylate-sodium—PTGS1—smooth muscle tissue—colon cancer	0.000909	0.0426	CbGeAlD
Salicylate-sodium—PTGS2—epithelium—colon cancer	0.000902	0.0422	CbGeAlD
Salicylate-sodium—Cerebrovascular accident—Irinotecan—colon cancer	0.000899	0.0063	CcSEcCtD
Salicylate-sodium—Cellulitis—Capecitabine—colon cancer	0.000893	0.00626	CcSEcCtD
Salicylate-sodium—Magnesium salicylate—PTGS2—colon cancer	0.00089	0.103	CrCbGaD
Salicylate-sodium—Hypocalcaemia—Capecitabine—colon cancer	0.000887	0.00622	CcSEcCtD
Salicylate-sodium—PTGS1—renal system—colon cancer	0.000875	0.041	CbGeAlD
Salicylate-sodium—Burning sensation—Methotrexate—colon cancer	0.000871	0.0061	CcSEcCtD
Salicylate-sodium—PTGS2—smooth muscle tissue—colon cancer	0.000869	0.0407	CbGeAlD
Salicylate-sodium—Lethargy—Fluorouracil—colon cancer	0.000861	0.00603	CcSEcCtD
Salicylate-sodium—Ulcer—Capecitabine—colon cancer	0.000859	0.00602	CcSEcCtD
Salicylate-sodium—Cyanosis—Methotrexate—colon cancer	0.000854	0.00598	CcSEcCtD
Salicylate-sodium—Hearing impaired—Capecitabine—colon cancer	0.000853	0.00598	CcSEcCtD
Salicylate-sodium—Dehydration—Vincristine—colon cancer	0.000841	0.00589	CcSEcCtD
Salicylate-sodium—PTGS2—renal system—colon cancer	0.000836	0.0392	CbGeAlD
Salicylate-sodium—Blood creatinine increased—Irinotecan—colon cancer	0.000826	0.00578	CcSEcCtD
Salicylate-sodium—Dehydration—Irinotecan—colon cancer	0.000819	0.00574	CcSEcCtD
Salicylate-sodium—Irritability—Fluorouracil—colon cancer	0.000806	0.00564	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Irinotecan—colon cancer	0.000802	0.00562	CcSEcCtD
Salicylate-sodium—Skin exfoliation—Capecitabine—colon cancer	0.000776	0.00543	CcSEcCtD
Salicylate-sodium—Fluid retention—Capecitabine—colon cancer	0.000771	0.0054	CcSEcCtD
Salicylate-sodium—Necrosis—Methotrexate—colon cancer	0.000771	0.0054	CcSEcCtD
Salicylate-sodium—Abdominal distension—Irinotecan—colon cancer	0.000767	0.00537	CcSEcCtD
Salicylate-sodium—Abscess—Methotrexate—colon cancer	0.000764	0.00535	CcSEcCtD
Salicylate-sodium—Salsalate—PTGS2—colon cancer	0.000757	0.0874	CrCbGaD
Salicylate-sodium—Oesophagitis—Capecitabine—colon cancer	0.000742	0.0052	CcSEcCtD
Salicylate-sodium—Sweating increased—Irinotecan—colon cancer	0.000742	0.0052	CcSEcCtD
Salicylate-sodium—Ecchymosis—Capecitabine—colon cancer	0.000735	0.00514	CcSEcCtD
Salicylate-sodium—Dysphagia—Fluorouracil—colon cancer	0.000729	0.00511	CcSEcCtD
Salicylate-sodium—PTGS1—digestive system—colon cancer	0.000718	0.0336	CbGeAlD
Salicylate-sodium—Sepsis—Capecitabine—colon cancer	0.000705	0.00494	CcSEcCtD
Salicylate-sodium—PTGS2—lymphoid tissue—colon cancer	0.000695	0.0325	CbGeAlD
Salicylate-sodium—Extravasation—Methotrexate—colon cancer	0.000693	0.00485	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Vincristine—colon cancer	0.000687	0.00481	CcSEcCtD
Salicylate-sodium—PTGS2—digestive system—colon cancer	0.000686	0.0321	CbGeAlD
Salicylate-sodium—Phlebitis—Capecitabine—colon cancer	0.000685	0.00479	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Vincristine—colon cancer	0.000683	0.00479	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Irinotecan—colon cancer	0.000669	0.00469	CcSEcCtD
Salicylate-sodium—Swelling—Capecitabine—colon cancer	0.000668	0.00468	CcSEcCtD
Salicylate-sodium—Renal failure—Irinotecan—colon cancer	0.000668	0.00467	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Irinotecan—colon cancer	0.000666	0.00466	CcSEcCtD
Salicylate-sodium—Deafness—Capecitabine—colon cancer	0.000659	0.00462	CcSEcCtD
Salicylate-sodium—Mesalazine—PTGS2—colon cancer	0.000657	0.0759	CrCbGaD
Salicylate-sodium—Oliguria—Methotrexate—colon cancer	0.000656	0.0046	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Fluorouracil—colon cancer	0.000641	0.00449	CcSEcCtD
Salicylate-sodium—Ulcer—Methotrexate—colon cancer	0.000639	0.00448	CcSEcCtD
Salicylate-sodium—Renal failure acute—Capecitabine—colon cancer	0.000639	0.00447	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Fluorouracil—colon cancer	0.000638	0.00446	CcSEcCtD
Salicylate-sodium—PTGS1—vagina—colon cancer	0.000634	0.0297	CbGeAlD
Salicylate-sodium—PTGS2—bone marrow—colon cancer	0.000632	0.0296	CbGeAlD
Salicylate-sodium—Hallucination—Vincristine—colon cancer	0.000623	0.00436	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Vincristine—colon cancer	0.000623	0.00436	CcSEcCtD
Salicylate-sodium—Renal impairment—Capecitabine—colon cancer	0.00062	0.00434	CcSEcCtD
Salicylate-sodium—Epistaxis—Fluorouracil—colon cancer	0.000613	0.0043	CcSEcCtD
Salicylate-sodium—PTGS2—vagina—colon cancer	0.000606	0.0284	CbGeAlD
Salicylate-sodium—Cerebrovascular accident—Capecitabine—colon cancer	0.000602	0.00421	CcSEcCtD
Salicylate-sodium—Lethargy—Capecitabine—colon cancer	0.000602	0.00421	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Fluorouracil—colon cancer	0.000581	0.00407	CcSEcCtD
Salicylate-sodium—Skin exfoliation—Methotrexate—colon cancer	0.000577	0.00404	CcSEcCtD
Salicylate-sodium—Acetylsalicylic acid—PTGS2—colon cancer	0.000565	0.0653	CrCbGaD
Salicylate-sodium—Irritability—Capecitabine—colon cancer	0.000563	0.00394	CcSEcCtD
Salicylate-sodium—Blood creatinine increased—Capecitabine—colon cancer	0.000552	0.00387	CcSEcCtD
Salicylate-sodium—Dehydration—Capecitabine—colon cancer	0.000548	0.00384	CcSEcCtD
Salicylate-sodium—Ecchymosis—Methotrexate—colon cancer	0.000547	0.00383	CcSEcCtD
Salicylate-sodium—Arrhythmia—Irinotecan—colon cancer	0.000545	0.00381	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Capecitabine—colon cancer	0.000539	0.00377	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Capecitabine—colon cancer	0.000537	0.00376	CcSEcCtD
Salicylate-sodium—Sepsis—Methotrexate—colon cancer	0.000525	0.00368	CcSEcCtD
Salicylate-sodium—Flatulence—Irinotecan—colon cancer	0.000523	0.00366	CcSEcCtD
Salicylate-sodium—Arrhythmia—Fluorouracil—colon cancer	0.000522	0.00365	CcSEcCtD
Salicylate-sodium—Abdominal distension—Capecitabine—colon cancer	0.000513	0.00359	CcSEcCtD
Salicylate-sodium—PTGS2—liver—colon cancer	0.000511	0.0239	CbGeAlD
Salicylate-sodium—Dysphagia—Capecitabine—colon cancer	0.00051	0.00357	CcSEcCtD
Salicylate-sodium—Asthma—Capecitabine—colon cancer	0.00051	0.00357	CcSEcCtD
Salicylate-sodium—Erythema—Fluorouracil—colon cancer	0.000508	0.00356	CcSEcCtD
Salicylate-sodium—Bronchospasm—Capecitabine—colon cancer	0.000501	0.00351	CcSEcCtD
Salicylate-sodium—Sweating increased—Capecitabine—colon cancer	0.000497	0.00348	CcSEcCtD
Salicylate-sodium—Bronchitis—Capecitabine—colon cancer	0.00049	0.00343	CcSEcCtD
Salicylate-sodium—Abdominal discomfort—Capecitabine—colon cancer	0.000489	0.00342	CcSEcCtD
Salicylate-sodium—Acetylsalicylic acid—ABCB1—colon cancer	0.000481	0.0555	CrCbGaD
Salicylate-sodium—Vision blurred—Fluorouracil—colon cancer	0.000479	0.00335	CcSEcCtD
Salicylate-sodium—Syncope—Irinotecan—colon cancer	0.000476	0.00333	CcSEcCtD
Salicylate-sodium—Renal failure acute—Methotrexate—colon cancer	0.000476	0.00333	CcSEcCtD
Salicylate-sodium—Convulsion—Vincristine—colon cancer	0.000472	0.00331	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Irinotecan—colon cancer	0.000466	0.00327	CcSEcCtD
Salicylate-sodium—Salicylic acid—PTGS2—colon cancer	0.000465	0.0538	CrCbGaD
Salicylate-sodium—Weight increased—Capecitabine—colon cancer	0.000464	0.00325	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Capecitabine—colon cancer	0.000448	0.00314	CcSEcCtD
Salicylate-sodium—Cerebrovascular accident—Methotrexate—colon cancer	0.000448	0.00314	CcSEcCtD
Salicylate-sodium—Lethargy—Methotrexate—colon cancer	0.000448	0.00314	CcSEcCtD
Salicylate-sodium—Renal failure—Capecitabine—colon cancer	0.000447	0.00313	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Capecitabine—colon cancer	0.000445	0.00312	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Vincristine—colon cancer	0.000445	0.00311	CcSEcCtD
Salicylate-sodium—Oedema—Vincristine—colon cancer	0.000445	0.00311	CcSEcCtD
Salicylate-sodium—Infection—Vincristine—colon cancer	0.000442	0.00309	CcSEcCtD
Salicylate-sodium—Convulsion—Fluorouracil—colon cancer	0.00044	0.00308	CcSEcCtD
Salicylate-sodium—Confusional state—Irinotecan—colon cancer	0.000437	0.00306	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Irinotecan—colon cancer	0.000433	0.00303	CcSEcCtD
Salicylate-sodium—Oedema—Irinotecan—colon cancer	0.000433	0.00303	CcSEcCtD
Salicylate-sodium—Chest pain—Fluorouracil—colon cancer	0.000433	0.00303	CcSEcCtD
Salicylate-sodium—Infection—Irinotecan—colon cancer	0.00043	0.00301	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Vincristine—colon cancer	0.00043	0.00301	CcSEcCtD
Salicylate-sodium—Epistaxis—Capecitabine—colon cancer	0.000429	0.003	CcSEcCtD
Salicylate-sodium—Shock—Irinotecan—colon cancer	0.000426	0.00298	CcSEcCtD
Salicylate-sodium—Anorexia—Vincristine—colon cancer	0.000424	0.00297	CcSEcCtD
Salicylate-sodium—Irritability—Methotrexate—colon cancer	0.000419	0.00293	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Irinotecan—colon cancer	0.000419	0.00293	CcSEcCtD
Salicylate-sodium—Confusional state—Fluorouracil—colon cancer	0.000418	0.00293	CcSEcCtD
Salicylate-sodium—Hypotension—Vincristine—colon cancer	0.000416	0.00291	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Fluorouracil—colon cancer	0.000415	0.0029	CcSEcCtD
Salicylate-sodium—Oedema—Fluorouracil—colon cancer	0.000415	0.0029	CcSEcCtD
Salicylate-sodium—Anorexia—Irinotecan—colon cancer	0.000413	0.00289	CcSEcCtD
Salicylate-sodium—Infection—Fluorouracil—colon cancer	0.000412	0.00289	CcSEcCtD
Salicylate-sodium—PTGS1—lymph node—colon cancer	0.00041	0.0192	CbGeAlD
Salicylate-sodium—Hepatitis—Capecitabine—colon cancer	0.000408	0.00286	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Capecitabine—colon cancer	0.000406	0.00284	CcSEcCtD
Salicylate-sodium—Tachycardia—Fluorouracil—colon cancer	0.000405	0.00284	CcSEcCtD
Salicylate-sodium—Hypotension—Irinotecan—colon cancer	0.000405	0.00283	CcSEcCtD
Salicylate-sodium—Paraesthesia—Vincristine—colon cancer	0.000399	0.0028	CcSEcCtD
Salicylate-sodium—Salicylic acid—ABCB1—colon cancer	0.000396	0.0457	CrCbGaD
Salicylate-sodium—Anorexia—Fluorouracil—colon cancer	0.000395	0.00277	CcSEcCtD
Salicylate-sodium—PTGS2—lymph node—colon cancer	0.000392	0.0183	CbGeAlD
Salicylate-sodium—Paraesthesia—Irinotecan—colon cancer	0.000389	0.00272	CcSEcCtD
Salicylate-sodium—Hypotension—Fluorouracil—colon cancer	0.000388	0.00271	CcSEcCtD
Salicylate-sodium—Decreased appetite—Vincristine—colon cancer	0.000387	0.00271	CcSEcCtD
Salicylate-sodium—Dyspnoea—Irinotecan—colon cancer	0.000386	0.0027	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Capecitabine—colon cancer	0.000386	0.0027	CcSEcCtD
Salicylate-sodium—Somnolence—Irinotecan—colon cancer	0.000385	0.0027	CcSEcCtD
Salicylate-sodium—Fatigue—Vincristine—colon cancer	0.000383	0.00269	CcSEcCtD
Salicylate-sodium—Dyspepsia—Irinotecan—colon cancer	0.000381	0.00267	CcSEcCtD
Salicylate-sodium—Tinnitus—Capecitabine—colon cancer	0.00038	0.00266	CcSEcCtD
Salicylate-sodium—Pain—Vincristine—colon cancer	0.00038	0.00266	CcSEcCtD
Salicylate-sodium—Constipation—Vincristine—colon cancer	0.00038	0.00266	CcSEcCtD
Salicylate-sodium—Asthma—Methotrexate—colon cancer	0.000379	0.00266	CcSEcCtD
Salicylate-sodium—Decreased appetite—Irinotecan—colon cancer	0.000376	0.00264	CcSEcCtD
Salicylate-sodium—Fatigue—Irinotecan—colon cancer	0.000373	0.00261	CcSEcCtD
Salicylate-sodium—Paraesthesia—Fluorouracil—colon cancer	0.000372	0.00261	CcSEcCtD
Salicylate-sodium—Constipation—Irinotecan—colon cancer	0.00037	0.00259	CcSEcCtD
Salicylate-sodium—Pain—Irinotecan—colon cancer	0.00037	0.00259	CcSEcCtD
Salicylate-sodium—Dyspnoea—Fluorouracil—colon cancer	0.00037	0.00259	CcSEcCtD
Salicylate-sodium—Somnolence—Fluorouracil—colon cancer	0.000369	0.00258	CcSEcCtD
Salicylate-sodium—Dyspepsia—Fluorouracil—colon cancer	0.000365	0.00256	CcSEcCtD
Salicylate-sodium—Arrhythmia—Capecitabine—colon cancer	0.000364	0.00255	CcSEcCtD
Salicylate-sodium—Abdominal discomfort—Methotrexate—colon cancer	0.000364	0.00255	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Vincristine—colon cancer	0.000364	0.00255	CcSEcCtD
Salicylate-sodium—Decreased appetite—Fluorouracil—colon cancer	0.000361	0.00253	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Irinotecan—colon cancer	0.000357	0.0025	CcSEcCtD
Salicylate-sodium—Erythema—Capecitabine—colon cancer	0.000355	0.00249	CcSEcCtD
Salicylate-sodium—Pain—Fluorouracil—colon cancer	0.000355	0.00248	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Irinotecan—colon cancer	0.000354	0.00248	CcSEcCtD
Salicylate-sodium—Body temperature increased—Vincristine—colon cancer	0.000352	0.00246	CcSEcCtD
Salicylate-sodium—Abdominal pain—Vincristine—colon cancer	0.000352	0.00246	CcSEcCtD
Salicylate-sodium—Flatulence—Capecitabine—colon cancer	0.00035	0.00245	CcSEcCtD
Salicylate-sodium—Dysgeusia—Capecitabine—colon cancer	0.000348	0.00244	CcSEcCtD
Salicylate-sodium—Body temperature increased—Irinotecan—colon cancer	0.000342	0.0024	CcSEcCtD
Salicylate-sodium—Abdominal pain—Irinotecan—colon cancer	0.000342	0.0024	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Fluorouracil—colon cancer	0.000342	0.00239	CcSEcCtD
Salicylate-sodium—Drowsiness—Methotrexate—colon cancer	0.000338	0.00237	CcSEcCtD
Salicylate-sodium—Vision blurred—Capecitabine—colon cancer	0.000335	0.00234	CcSEcCtD
Salicylate-sodium—Renal failure—Methotrexate—colon cancer	0.000333	0.00233	CcSEcCtD
Salicylate-sodium—Urticaria—Fluorouracil—colon cancer	0.00033	0.00231	CcSEcCtD
Salicylate-sodium—Body temperature increased—Fluorouracil—colon cancer	0.000328	0.0023	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Vincristine—colon cancer	0.000328	0.00229	CcSEcCtD
Salicylate-sodium—Epistaxis—Methotrexate—colon cancer	0.000319	0.00223	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Irinotecan—colon cancer	0.000319	0.00223	CcSEcCtD
Salicylate-sodium—Asthenia—Vincristine—colon cancer	0.000319	0.00223	CcSEcCtD
Salicylate-sodium—Syncope—Capecitabine—colon cancer	0.000319	0.00223	CcSEcCtD
Salicylate-sodium—Palpitations—Capecitabine—colon cancer	0.000314	0.0022	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Capecitabine—colon cancer	0.000312	0.00219	CcSEcCtD
Salicylate-sodium—Asthenia—Irinotecan—colon cancer	0.000311	0.00218	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Fluorouracil—colon cancer	0.000306	0.00214	CcSEcCtD
Salicylate-sodium—Diarrhoea—Vincristine—colon cancer	0.000304	0.00213	CcSEcCtD
Salicylate-sodium—Hepatitis—Methotrexate—colon cancer	0.000304	0.00213	CcSEcCtD
Salicylate-sodium—Chest pain—Capecitabine—colon cancer	0.000302	0.00212	CcSEcCtD
Salicylate-sodium—Anxiety—Capecitabine—colon cancer	0.000301	0.00211	CcSEcCtD
Salicylate-sodium—Diarrhoea—Irinotecan—colon cancer	0.000296	0.00208	CcSEcCtD
Salicylate-sodium—Dizziness—Vincristine—colon cancer	0.000294	0.00206	CcSEcCtD
Salicylate-sodium—Pruritus—Fluorouracil—colon cancer	0.000293	0.00206	CcSEcCtD
Salicylate-sodium—Confusional state—Capecitabine—colon cancer	0.000292	0.00205	CcSEcCtD
Salicylate-sodium—Oedema—Capecitabine—colon cancer	0.00029	0.00203	CcSEcCtD
Salicylate-sodium—Infection—Capecitabine—colon cancer	0.000288	0.00202	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Methotrexate—colon cancer	0.000287	0.00201	CcSEcCtD
Salicylate-sodium—Dizziness—Irinotecan—colon cancer	0.000286	0.00201	CcSEcCtD
Salicylate-sodium—Shock—Capecitabine—colon cancer	0.000285	0.002	CcSEcCtD
Salicylate-sodium—Diarrhoea—Fluorouracil—colon cancer	0.000284	0.00199	CcSEcCtD
Salicylate-sodium—Tinnitus—Methotrexate—colon cancer	0.000283	0.00198	CcSEcCtD
Salicylate-sodium—Tachycardia—Capecitabine—colon cancer	0.000283	0.00198	CcSEcCtD
Salicylate-sodium—Vomiting—Vincristine—colon cancer	0.000283	0.00198	CcSEcCtD
Salicylate-sodium—Rash—Vincristine—colon cancer	0.00028	0.00196	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Capecitabine—colon cancer	0.00028	0.00196	CcSEcCtD
Salicylate-sodium—Dermatitis—Vincristine—colon cancer	0.00028	0.00196	CcSEcCtD
Salicylate-sodium—Headache—Vincristine—colon cancer	0.000279	0.00195	CcSEcCtD
Salicylate-sodium—Anorexia—Capecitabine—colon cancer	0.000276	0.00193	CcSEcCtD
Salicylate-sodium—Vomiting—Irinotecan—colon cancer	0.000275	0.00193	CcSEcCtD
Salicylate-sodium—Dizziness—Fluorouracil—colon cancer	0.000274	0.00192	CcSEcCtD
Salicylate-sodium—Rash—Irinotecan—colon cancer	0.000273	0.00191	CcSEcCtD
Salicylate-sodium—Dermatitis—Irinotecan—colon cancer	0.000273	0.00191	CcSEcCtD
Salicylate-sodium—Headache—Irinotecan—colon cancer	0.000271	0.0019	CcSEcCtD
Salicylate-sodium—Hypotension—Capecitabine—colon cancer	0.000271	0.0019	CcSEcCtD
Salicylate-sodium—Erythema—Methotrexate—colon cancer	0.000264	0.00185	CcSEcCtD
Salicylate-sodium—Nausea—Vincristine—colon cancer	0.000264	0.00185	CcSEcCtD
Salicylate-sodium—Vomiting—Fluorouracil—colon cancer	0.000264	0.00185	CcSEcCtD
Salicylate-sodium—Rash—Fluorouracil—colon cancer	0.000262	0.00183	CcSEcCtD
Salicylate-sodium—Dermatitis—Fluorouracil—colon cancer	0.000261	0.00183	CcSEcCtD
Salicylate-sodium—Paraesthesia—Capecitabine—colon cancer	0.00026	0.00182	CcSEcCtD
Salicylate-sodium—Headache—Fluorouracil—colon cancer	0.00026	0.00182	CcSEcCtD
Salicylate-sodium—Dysgeusia—Methotrexate—colon cancer	0.000259	0.00181	CcSEcCtD
Salicylate-sodium—Dyspnoea—Capecitabine—colon cancer	0.000258	0.00181	CcSEcCtD
Salicylate-sodium—Nausea—Irinotecan—colon cancer	0.000257	0.0018	CcSEcCtD
Salicylate-sodium—Dyspepsia—Capecitabine—colon cancer	0.000255	0.00179	CcSEcCtD
Salicylate-sodium—Decreased appetite—Capecitabine—colon cancer	0.000252	0.00176	CcSEcCtD
Salicylate-sodium—Fatigue—Capecitabine—colon cancer	0.00025	0.00175	CcSEcCtD
Salicylate-sodium—Vision blurred—Methotrexate—colon cancer	0.000249	0.00174	CcSEcCtD
Salicylate-sodium—Pain—Capecitabine—colon cancer	0.000248	0.00174	CcSEcCtD
Salicylate-sodium—Constipation—Capecitabine—colon cancer	0.000248	0.00174	CcSEcCtD
Salicylate-sodium—Nausea—Fluorouracil—colon cancer	0.000246	0.00173	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Capecitabine—colon cancer	0.000239	0.00167	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Capecitabine—colon cancer	0.000237	0.00166	CcSEcCtD
Salicylate-sodium—Urticaria—Capecitabine—colon cancer	0.00023	0.00161	CcSEcCtD
Salicylate-sodium—Abdominal pain—Capecitabine—colon cancer	0.000229	0.0016	CcSEcCtD
Salicylate-sodium—Body temperature increased—Capecitabine—colon cancer	0.000229	0.0016	CcSEcCtD
Salicylate-sodium—Convulsion—Methotrexate—colon cancer	0.000229	0.0016	CcSEcCtD
Salicylate-sodium—Chest pain—Methotrexate—colon cancer	0.000225	0.00158	CcSEcCtD
Salicylate-sodium—Confusional state—Methotrexate—colon cancer	0.000218	0.00152	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Methotrexate—colon cancer	0.000216	0.00151	CcSEcCtD
Salicylate-sodium—Infection—Methotrexate—colon cancer	0.000214	0.0015	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Capecitabine—colon cancer	0.000214	0.0015	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Methotrexate—colon cancer	0.000209	0.00146	CcSEcCtD
Salicylate-sodium—Asthenia—Capecitabine—colon cancer	0.000208	0.00146	CcSEcCtD
Salicylate-sodium—Anorexia—Methotrexate—colon cancer	0.000206	0.00144	CcSEcCtD
Salicylate-sodium—Pruritus—Capecitabine—colon cancer	0.000205	0.00144	CcSEcCtD
Salicylate-sodium—Hypotension—Methotrexate—colon cancer	0.000202	0.00141	CcSEcCtD
Salicylate-sodium—Diarrhoea—Capecitabine—colon cancer	0.000198	0.00139	CcSEcCtD
Salicylate-sodium—Paraesthesia—Methotrexate—colon cancer	0.000194	0.00136	CcSEcCtD
Salicylate-sodium—Dyspnoea—Methotrexate—colon cancer	0.000192	0.00135	CcSEcCtD
Salicylate-sodium—Somnolence—Methotrexate—colon cancer	0.000192	0.00134	CcSEcCtD
Salicylate-sodium—Dizziness—Capecitabine—colon cancer	0.000192	0.00134	CcSEcCtD
Salicylate-sodium—Dyspepsia—Methotrexate—colon cancer	0.00019	0.00133	CcSEcCtD
Salicylate-sodium—Decreased appetite—Methotrexate—colon cancer	0.000188	0.00131	CcSEcCtD
Salicylate-sodium—Fatigue—Methotrexate—colon cancer	0.000186	0.0013	CcSEcCtD
Salicylate-sodium—Pain—Methotrexate—colon cancer	0.000185	0.00129	CcSEcCtD
Salicylate-sodium—Vomiting—Capecitabine—colon cancer	0.000184	0.00129	CcSEcCtD
Salicylate-sodium—Rash—Capecitabine—colon cancer	0.000183	0.00128	CcSEcCtD
Salicylate-sodium—Dermatitis—Capecitabine—colon cancer	0.000183	0.00128	CcSEcCtD
Salicylate-sodium—Headache—Capecitabine—colon cancer	0.000182	0.00127	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Methotrexate—colon cancer	0.000178	0.00125	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Methotrexate—colon cancer	0.000176	0.00124	CcSEcCtD
Salicylate-sodium—Nausea—Capecitabine—colon cancer	0.000172	0.00121	CcSEcCtD
Salicylate-sodium—Urticaria—Methotrexate—colon cancer	0.000171	0.0012	CcSEcCtD
Salicylate-sodium—Abdominal pain—Methotrexate—colon cancer	0.000171	0.00119	CcSEcCtD
Salicylate-sodium—Body temperature increased—Methotrexate—colon cancer	0.000171	0.00119	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Methotrexate—colon cancer	0.000159	0.00111	CcSEcCtD
Salicylate-sodium—Asthenia—Methotrexate—colon cancer	0.000155	0.00108	CcSEcCtD
Salicylate-sodium—Pruritus—Methotrexate—colon cancer	0.000153	0.00107	CcSEcCtD
Salicylate-sodium—Diarrhoea—Methotrexate—colon cancer	0.000148	0.00103	CcSEcCtD
Salicylate-sodium—Dizziness—Methotrexate—colon cancer	0.000143	0.000999	CcSEcCtD
Salicylate-sodium—Vomiting—Methotrexate—colon cancer	0.000137	0.000961	CcSEcCtD
Salicylate-sodium—Rash—Methotrexate—colon cancer	0.000136	0.000953	CcSEcCtD
Salicylate-sodium—Dermatitis—Methotrexate—colon cancer	0.000136	0.000952	CcSEcCtD
Salicylate-sodium—Headache—Methotrexate—colon cancer	0.000135	0.000947	CcSEcCtD
Salicylate-sodium—Nausea—Methotrexate—colon cancer	0.000128	0.000898	CcSEcCtD
